Rheumatology Advances in Practice

Oxford University Press

Journal websitePeer review: Other
Evaluation status available after sign-in

About the journal

Rheumatology Advances in Practice is an open-access journal published by Oxford University Press in United Kingdom, publishing in english. It is listed in DOAJ according to the sources read. Declared publication charge: 2,148 GBP. Declared review time at DOAJ: 11 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Oxford University Press
ISSN
2514-1775
Country
United Kingdom
Languages
english
Access
Open access
Declared publication charge
2,148 GBP
Articles in DOAJ
0
Declared review time
11 weeks
Declared peer-review model
other

Index listings

  • DOAJ · 2018-05-23
Indexing
DOAJ
APC
2,148 GBP
Declared review time (DOAJ)
11 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

11weeks

Works in OpenAlex

1639

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

29

i10-index

161

From OpenAlex open data (CC0).

Editorial & policy13
Last DOAJ review date
2024-04-03
Added to DOAJ
2018-05-23
Declared plagiarism screening
Declared
Other fees beyond APC
No
Declared digital preservation
PMC
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
60%
ORCID iDs in current deposits
58%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
APC waiver policy
View policy
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
101736676
Classification4

Subjects (DOAJ)

Medicine: Surgery: Orthopedic surgeryMedicine: Internal medicine: Specialties of internal medicine: Diseases of the musculoskeletal system

LCC codes

RD701-811RC925-935

Subject areas

  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Rheumatoid Arthritis Research and Therapies
  • Vasculitis and related conditions
  • Spondyloarthritis Studies and Treatments
  • Spondyloarthritis Studies and Treatments
  • Systemic Sclerosis and Related Diseases
  • Autoimmune and Inflammatory Disorders Research
Show all subjects (75)
  • Inflammatory Myopathies and Dermatomyositis
  • Inflammatory Myopathies and Dermatomyositis
  • Systemic Lupus Erythematosus Research
  • Vasculitis and related conditions
  • Vasculitis and related conditions
  • Systemic Lupus Erythematosus Research
  • Systemic Lupus Erythematosus Research
  • Inflammatory Myopathies and Dermatomyositis
  • Spondyloarthritis Studies and Treatments
  • Systemic Sclerosis and Related Diseases
  • Systemic Sclerosis and Related Diseases
  • Autoimmune and Inflammatory Disorders Research
  • Autoimmune and Inflammatory Disorders Research
  • Musculoskeletal pain and rehabilitation
  • Ocular Diseases and Behçet’s Syndrome
  • Otitis Media and Relapsing Polychondritis
  • Otitis Media and Relapsing Polychondritis
  • Gout, Hyperuricemia, Uric Acid
  • Gout, Hyperuricemia, Uric Acid
  • Gout, Hyperuricemia, Uric Acid
  • Musculoskeletal Disorders and Rehabilitation
  • Musculoskeletal Disorders and Rehabilitation
  • Myasthenia Gravis and Thymoma
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Sarcoidosis and Beryllium Toxicity Research
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Osteomyelitis and Bone Disorders Research
  • Otitis Media and Relapsing Polychondritis
  • Kawasaki Disease and Coronary Complications
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Ocular Diseases and Behçet’s Syndrome
  • Ocular Diseases and Behçet’s Syndrome
  • Sarcoidosis and Beryllium Toxicity Research
  • Psoriasis: Treatment and Pathogenesis
  • Psoriasis: Treatment and Pathogenesis
  • Musculoskeletal Disorders and Rehabilitation
  • Sarcoidosis and Beryllium Toxicity Research
  • Inflammasome and immune disorders
  • COVID-19 Clinical Research Studies
  • Psoriasis: Treatment and Pathogenesis
  • Bone and Joint Diseases
  • Skin Diseases and Diabetes
  • Bone and Joint Diseases
  • Skin Diseases and Diabetes
  • Peripheral Neuropathies and Disorders
  • Infectious Diseases and Tuberculosis
  • Infectious Diseases and Tuberculosis
  • Adolescent and Pediatric Healthcare
  • Osteoarthritis Treatment and Mechanisms
  • Eosinophilic Disorders and Syndromes
  • Parkinson's Disease and Spinal Disorders
  • Adolescent and Pediatric Healthcare
  • Parkinson's Disease and Spinal Disorders
  • Eosinophilic Disorders and Syndromes
  • Osteoarthritis Treatment and Mechanisms
  • Autoimmune and Inflammatory Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Immunodeficiency and Autoimmune Disorders
  • Renal Diseases and Glomerulopathies
  • Osteomyelitis and Bone Disorders Research
  • Osteomyelitis and Bone Disorders Research
  • Inflammasome and immune disorders
  • Muscle and Compartmental Disorders
  • Inflammasome and immune disorders
  • Muscle and Compartmental Disorders
  • Pulmonary Hypertension Research and Treatments
  • Salivary Gland Disorders and Functions

Keywords (DOAJ)

  • orthopaedics
  • rheumatology
  • musculoskeletal disorders
  • rheumatological diseases
  • inflammatory diseases
  • connective tissue diseases

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: